Rowena V. Cube

Statistics

Publications

Citations

523

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

General Atomics (United States)

United States Military Academy

The Ohio State University at Marion

Rowena V. Cube is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, neuropharmacology, and molecular pharmacology.

Publications per year

1990–2014

Publications

Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain

Adam Kesingland, Clive Gentry, Moh Panesar et al. · Pain · 2000 · 81 citations

Medicine, Neurobiology, Pharmacology +17

The Use of Pearlman's Catalyst for Selective<i>N</i>-Debenzylation in the Presence of Benzyl Ethers

Ronald C. Bernotas, Rowena V. Cube · Synthetic Communications · 1990 · 69 citations

Natural Sciences, Chemistry, Catalysis +10

The use of triphenylphosphine/diethyl azodicarboxylate (dead) for the cyclization of 1,4- and 1,5-amino alcohols

Ronald C. Bernotas, Rowena V. Cube · Tetrahedron Letters · 1991 · 53 citations

Natural Sciences, Biochemistry, Chemistry +4

Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators

Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 49 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Diaryl substituted pyrazoles as potent CCR2 receptor antagonists

Anthony B. Pinkerton, Dehua Huang, Rowena V. Cube et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 14